The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-(3-(5-Methyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid ID: ALA4243367
PubChem CID: 145983050
Max Phase: Preclinical
Molecular Formula: C28H35N5O2
Molecular Weight: 473.62
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccnn1-c1cccc([C@H](CC(=O)O)CN2CC[C@@H](CCc3ccc4c(n3)NCCC4)C2)c1
Standard InChI: InChI=1S/C28H35N5O2/c1-20-11-14-30-33(20)26-6-2-4-23(16-26)24(17-27(34)35)19-32-15-12-21(18-32)7-9-25-10-8-22-5-3-13-29-28(22)31-25/h2,4,6,8,10-11,14,16,21,24H,3,5,7,9,12-13,15,17-19H2,1H3,(H,29,31)(H,34,35)/t21-,24-/m1/s1
Standard InChI Key: SFSRFYDTGQPIJA-ZJSXRUAMSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
32.8503 -10.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6353 -10.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0954 -9.5652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5925 -8.9179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8257 -9.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9923 -9.2023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7020 -8.7928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6991 -7.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9905 -7.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2843 -8.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2884 -7.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5846 -7.5627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8722 -7.9666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8680 -8.7862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5763 -9.2018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4103 -9.2003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1174 -8.7906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9122 -9.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3428 -10.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1596 -10.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9565 -10.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5901 -10.9031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4069 -10.8775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2039 -11.6233 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.1393 -10.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7531 -11.6976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1838 -12.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0047 -12.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3872 -11.6450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4377 -13.0578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1355 -13.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7615 -14.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4546 -13.9078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2568 -13.1149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3431 -14.0149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
10 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 11 1 0
10 11 2 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
7 16 1 0
16 17 1 0
5 17 1 1
3 18 1 0
18 19 1 0
19 20 1 0
19 21 1 1
20 22 1 0
22 23 1 0
22 24 2 0
21 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 21 1 0
28 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 30 1 0
31 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 473.62Molecular Weight (Monoisotopic): 473.2791AlogP: 4.45#Rotatable Bonds: 9Polar Surface Area: 83.28Molecular Species: ZWITTERIONHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.05CX Basic pKa: 10.26CX LogP: 1.22CX LogD: 1.00Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.48Np Likeness Score: -0.89
References 1. Procopiou PA, Anderson NA, Barrett J, Barrett TN, Crawford MHJ, Fallon BJ, Hancock AP, Le J, Lemma S, Marshall RP, Morrell J, Pritchard JM, Rowedder JE, Saklatvala P, Slack RJ, Sollis SL, Suckling CJ, Thorp LR, Vitulli G, Macdonald SJF.. (2018) Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis., 61 (18): [PMID:30215258 ] [10.1021/acs.jmedchem.8b00959 ]